Publication
Strong nocebo effect in amyotrophic lateral sclerosis trials might mask conclusions.
dc.contributor.author | Rato, M | |
dc.contributor.author | Duarte, G | |
dc.contributor.author | Mestre, T | |
dc.contributor.author | Carvalho, M | |
dc.contributor.author | Ferreira, J | |
dc.date.accessioned | 2018-11-21T16:34:26Z | |
dc.date.available | 2018-11-21T16:34:26Z | |
dc.date.issued | 2018 | |
dc.description.version | info:eu-repo/semantics/publishedVersion | pt_PT |
dc.identifier.citation | Lancet Neurol. 2018 Oct;17(10):842 | pt_PT |
dc.identifier.doi | 10.1016/S1474-4422(18)30310-7 | pt_PT |
dc.identifier.issn | 1474-4465 | |
dc.identifier.uri | http://hdl.handle.net/10400.10/2060 | |
dc.language.iso | eng | pt_PT |
dc.peerreviewed | yes | pt_PT |
dc.publisher | Lancet Pub. Group | pt_PT |
dc.subject | Amyotrophic lateral sclerosis | pt_PT |
dc.title | Strong nocebo effect in amyotrophic lateral sclerosis trials might mask conclusions. | pt_PT |
dc.type | journal article | |
dspace.entity.type | Publication | |
oaire.citation.conferencePlace | London | pt_PT |
oaire.citation.endPage | 842 | pt_PT |
oaire.citation.startPage | 842 | pt_PT |
oaire.citation.title | Lancet Neurology | pt_PT |
oaire.citation.volume | 17 | pt_PT |
rcaap.rights | closedAccess | pt_PT |
rcaap.type | article | pt_PT |